OSE IMMUNOTHERAPEUTICS

Analyst Reco. OSE Immunotherapeutics

Equities

OSE

FR0012127173

Market Closed - Euronext Paris Other stock markets 11:35:12 2024-04-29 EDT			5-day change	1st Jan Change
5.52 ^EUR	-0.72%		-7.54%	+28.97%

04-17	OSE: licensing agreement with AbbVie enters into force	CF
04-17	OSE Immunotherapeutics Finalizes Drug License, Collaboration Deal With AbbVie	MT

Analyst Reco.

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

OSE IMMUNOTHERAPEUTICS : Degroof Petercam reiterates buy recommendation	03-18	CF
OSE IMMUNO : Oddo BHF confirms its recommendation	23-07-06	CF
OSE IMMUNO : Invest Securities confirms its recommendation	23-07-06	CF
OSE IMMUNO : Invest Securities confirms its recommendation	23-06-27	CF
Ose Immuno: share price falls, broker lowers target	23-05-16	CF
OSE IMMUNO : Invest Securities lowers its target	23-05-16	CF
TODAY'S ANALYST RECOMMENDATIONS : Barclays, Ford, Microsoft, Oracle, Lloyds...	21-05-18

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

All transcripts on over 9000 companies, on the day they post their earnings!

Unlock them now!

fermer